Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection.
about
ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challengeAntibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaquesAge-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection.A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assaysStandard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG.HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality.HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development.Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.Conserved HIV Epitopes for an Effective HIV Vaccine.Systems serology: profiling vaccine induced humoral immunity against HIV.Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response.
P2860
Q27342615-A8385D85-44BD-48CA-A64E-D0C99F8A2DB2Q30427950-5ACD1E2B-EE12-4C55-B2D3-2B406934A944Q30432591-E551EF1C-C3E1-4C9C-8B6E-1810FF089D53Q34305570-4825D418-1F89-4381-8A70-D71BFCAF91D9Q34869927-BD31B80C-8BDE-4F7F-AEDB-32C582D2F2FBQ36086748-FC8A7EB4-74C8-4137-AF5D-89215E48B1C0Q36363866-AF00E3DE-2A93-4B3A-9DC8-68491D5FC2F6Q37336804-87B50859-922F-41A6-925C-043CFC2319B2Q37426168-1A474AD6-8E15-4ABF-8813-FB79A61DBDEBQ37505357-2E86028C-2B38-4FFE-AF56-8514CFCDD746Q37646897-AF1C3663-04B8-4893-AC6F-FDD26F2B28DFQ38061191-4F219244-899F-4F4A-9EB1-89BB89945924Q38682077-83A6FE80-444E-4B84-922B-DB598F928E54Q42159772-E41D6AEE-BCEC-4D54-B53A-F6FA718033ADQ43454270-AE6B542E-254A-485B-A81B-43DE77F0261FQ47093684-C6FEB184-CECD-4FBF-B14B-D7F4B38DDBD4Q47104983-2D108C64-A1FB-4DEE-80A0-B8E301506181Q52805871-56DB8C3D-29C1-4D8F-933E-787921949E00Q55154648-884DBEF0-04BF-4046-9BB2-43D76D21CD33Q55493835-A88C76EF-72E4-427B-93B8-1E13204E2C41
P2860
Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pol as a target for antibody d ...... responses in HIV-1 infection.
@en
Pol as a target for antibody d ...... responses in HIV-1 infection.
@nl
type
label
Pol as a target for antibody d ...... responses in HIV-1 infection.
@en
Pol as a target for antibody d ...... responses in HIV-1 infection.
@nl
prefLabel
Pol as a target for antibody d ...... responses in HIV-1 infection.
@en
Pol as a target for antibody d ...... responses in HIV-1 infection.
@nl
P2860
P50
P1433
P1476
Pol as a target for antibody d ...... responses in HIV-1 infection.
@en
P2093
Gamze Isitman
Marjon Navis
P2860
P304
P356
10.1016/J.VIROL.2010.12.044
P407
P577
2011-01-26T00:00:00Z